BFA
CRDF icon

BlackRock Fund Advisors’s Cardiff Oncology CRDF Stock Holding History

BlackRock Fund Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.88M Buy
12,454
+1,676
+16% +$391K ﹤0.01% 3175
2016
Q3 		$3.48M Buy
10,778
+465
+5% +$170K ﹤0.01% 3017
2016
Q2 		$3.36M Sell
10,313
-457
-4% -$157K ﹤0.01% 3026
2016
Q1 		$3.61M Sell
10,770
-440
-4% -$150K ﹤0.01% 2907
2015
Q4 		$4.36M Buy
11,210
+516
+5% +$202K ﹤0.01% 2906
2015
Q3 		$4.38M Buy
10,694
+1,748
+20% +$915K ﹤0.01% 2865
2015
Q2 		$6.54M Buy
8,946
+8,065
+915% +$5.72M ﹤0.01% 2762
2015
Q1 		$432K Sell
881
-59
-6% -$25.2K ﹤0.01% 3290
2014
Q4 		$291K Buy
940
+38
+4% +$12.3K ﹤0.01% 3378
2014
Q3 		$297K Sell
902
-65
-7% -$19.5K ﹤0.01% 3339
2014
Q2 		$244K Buy
967
+28
+3% +$8.97K ﹤0.01% 3419
2014
Q1 		$388K Buy
939
+114
+14% +$49.3K ﹤0.01% 3290
2013
Q4 		$341K Buy
825
+34
+4% +$15.1K ﹤0.01% 3281
2013
Q3 		$409K Buy
791
+188
+31% +$107K ﹤0.01% 3219
2013
Q2 		$304K Buy
+603
New +$273K ﹤0.01% 3214

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BlackRock Fund Advisors's CRDF Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Cardiff Oncology (CRDF) stake by 16% in Q4 2016, buying an estimated $391K and bringing the position to 12,454 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

BlackRock Fund Advisors first reported a position in CRDF in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.54M in Q2 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

  • BlackRock Fund Advisors held 12,454 shares of Cardiff Oncology worth $1.88M as of Q4 2016.
  • BlackRock Fund Advisors bought 1,676 Cardiff Oncology shares in Q4 2016, an estimated $391K.
  • Cardiff Oncology made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3175 holding.
  • BlackRock Fund Advisors first reported a position in Cardiff Oncology in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Cardiff Oncology position peaked at $6.54M in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.